HMMJ:CA:TSX-Horizons Marijuana Life Sciences Index ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 10.27

Change

+0.08 (+0.79)%

Market Cap

CAD 0.08B

Volume

3.18K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.07 (-0.19%)

CAD 2.34B
ZWU:CA BMO Covered Call Utilities ETF

+0.07 (+0.68%)

CAD 1.75B
XIT:CA iShares S&P/TSX Capped Informa..

-2.38 (-4.45%)

CAD 0.65B
TXF:CA First Asset Tech Giants Covere..

-0.01 (-0.05%)

CAD 0.60B
XHC:CA iShares Global Healthcare (CAD..

-0.17 (-0.24%)

CAD 0.58B
HTA:CA Tech Achievers Growth & Income..

+0.01 (+0.06%)

CAD 0.55B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.21 (+1.07%)

CAD 0.41B
HHL:CA Harvest Healthcare Leaders Inc..

-0.03 (-0.36%)

CAD 0.33B
CWW:CA iShares Global Water Common Cl..

+0.19 (+0.33%)

CAD 0.32B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.25 (+0.98%)

CAD 0.32B

ETFs Containing HMMJ:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.55% 93% A 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.55% 93% A 74% C
Trailing 12 Months  
Capital Gain 4.16% 47% F 52% F
Dividend Return 1.93% 60% D- 32% F
Total Return 6.09% 40% F 52% F
Trailing 5 Years  
Capital Gain -75.81% 6% D- 6% D-
Dividend Return 4.80% 38% F 20% F
Total Return -71.02% 6% D- 6% D-
Average Annual (5 Year Horizon)  
Capital Gain -10.59% 6% D- 6% D-
Dividend Return -8.20% 6% D- 7% C-
Total Return 2.39% 66% D+ 63% D
Risk Return Profile  
Volatility (Standard Deviation) 42.93% 9% A- 21% F
Risk Adjusted Return -19.11% 9% A- 23% F
Market Capitalization 0.08B 54% F 33% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.